Cancer Series Module 4: Cancer Associated Cognitive Impairment
Cancer Series Module 4: Cancer Associated Cognitive Impairment
Sorry! Image not available at this time


Publisher: AOTA Continuing Education

Published: 2017

Member Price
Non-Member Price: $64.95

Product Overview

Get an AOTA Digital Badge on Cancer Rehabilitation to share your learning accomplishment when you complete the required CE.

Get details here

Module Author:

Robin Newman OTD, OTR/L, CLT, CDRS

Series Editors:

Claudine Campbell, MOT, OTR, CLT

Lauro Munoz, OTR, MOT, FAOTA

Earn .15 AOTA CEU (1.88 NBCOT PDUs/1.5 contact hours)

Learning Objectives

After you have completed the lesson on Cancer Associated Cognitive Impairment, you should be able to:

·         Identify the role of OT in addressing cancer associated cognitive impairment in cancer survivors

·         Discuss the multi-factorial etiology of cancer associated cognitive impairment in cancer survivors.

·         Explain evidence-based assessment and intervention strategies to address cancer associated cognitive impairment that support occupational performance and participation in meaningful occupation

An emerging area for occupational therapy intervention in oncology includes addressing the impact of cancer related cognitive impairment on occupational performance. There are currently 14.5 million cancer survivors in the United States (ACS, 2014), with unique occupational strengths and potential restrictions in self-care, work, leisure and social participation. The number of cancer survivors is expected to increase to almost 19 million by 2024 (ACS, 2014) and a growing need is upon occupational therapy practitioners to implement evidence-based intervention and assessment methods to address the needs of cancer survivors throughout the continuum of care.